JAX strives to advance rare disease research and treatment options

For the past six years, the JAX Rare Disease Translational Center has worked with dozens of rare disease foundations to create custom mouse models that represent rare medical conditions, the majority of which present in young children.

In May 2022, JAX appointed Cathleen (Cat) Lutz, Ph.D., M.B.A. as Vice President of the Rare Disease Translational Center, marking an important step forward in its commitment to rare disease research. The expansion positions the Center to play an integral role throughout the entire rare disease odyssey, from diagnosis to research to drug development. The Center also collaborates closely with biotech and pharmaceutical companies to accelerate the path to drug discovery for these debilitating conditions. By taking a more holistic approach, the Center will make a significant impact on the experience of those living with rare diseases. Read more

Related Posts

Portland startup Marin Skincare launches lobster-based lip treatment

Portland startup Marin Skincare, known for its “lobster lotion,” is expanding that product line to include lip treatments.  Founded out of the University...

20 November 2023

UMaine scientists use eDNA to enhance river herring recovery research in Penobscot River

University of Maine researchers are seeking to gain more insight into river herring recovery in the Penobscot River using a novel...

16 November 2023

FocusMaine co-founder named group’s next president

Nearly a decade after Andrea Cianchette Maker joined forces with Michael Dubyak to launch FocusMaine, Maker will lead the organization as...

15 November 2023